Aster Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Aster Capital Management's BIO Position: Q3 2026 in Review
Aster Capital Management opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2026: 1,056 shares worth $399K. The stake represents 0.15% of the portfolio and ranks #233 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in BIO as recently as Q1 2026.
Aster Capital Management first reported a position in BIO in Q3 2024 and has held it in 6 quarters since. The position peaked at $648K in Q1 2025. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Aster Capital Management held 1,056 shares of Bio-Rad Laboratories Class A worth $399K as of Q3 2026.
- Bio-Rad Laboratories Class A was a new Aster Capital Management position in Q3 2026.
- Bio-Rad Laboratories Class A made up 0.15% of Aster Capital Management's portfolio in Q3 2026, its #233 holding.
- Aster Capital Management first reported a position in Bio-Rad Laboratories Class A in Q3 2024 and has held it in 6 quarters since.
- Aster Capital Management's Bio-Rad Laboratories Class A position peaked at $648K in Q1 2025.
- 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.